116
|
395
|
7s25A |
Rock1 in complex with ligand g4998 |
97
|
291
|
7nzyA |
Crystal structure of human casein kinase i delta in complex with cgs-15943 |
118
|
333
|
7qgcA |
H. sapiens ck2 kinase alpha subunit in complex with the atp-competitive inhibitor 5,6-dibromobenzotriazole at ph 5.5 |
42
|
210
|
7z37CP1 |
Structure of the raf1-hsp90-cdc37 complex (rhc-ii) |
89
|
293
|
8ahgA |
Pac-fragmentdel: photoactivated covalent capture of dna encoded fragments for hit discovery |
86
|
293
|
8ahhA |
Pac fragmentdel: photoactivated covalent capture of dna encoded fragments for hit discovery |
31
|
210
|
7z38C |
Structure of the raf1-hsp90-cdc37 complex (rhc-i) |
83
|
292
|
8ahiA |
Pac-fragmentdel: photoactivated covalent capture of dna encoded fragments for hit discovery |
358
|
1063
|
7pg5A |
Crystal structure of pi3kalpha |
354
|
1063
|
7pg6A |
Crystal structure of pi3kalpha in complex with the inhibitor nvp-byl719 |
191
|
1393
|
7v7bA |
Cryoem structure of ddb1-vprbp complex in arm-up conformation |
79
|
272
|
7up6A |
Crystal structure of c-terminal domain of msk1 in complex with in covalently bound literature rsk2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal) |
88
|
307
|
8aauL |
Lim domain kinase 1 (limk1) bound to limki3 |
88
|
364
|
8ahpA |
The crystal structure of the truncated form of lotus japonicus kinase 1 |
79
|
265
|
7ficA |
Reversible lysine-targeted probes reveal residence time-based kinase selectivity in vivo |
92
|
295
|
8dksA |
Irak4 in complex with compound #3 |
42
|
205
|
7vs7A |
Crystal structure of the ectodomain of oscerk1 in complex with chitin hexamer |
120
|
348
|
7q4aA |
Toxoplasma gondii prp4k kinase domain (l715f) bound to altiratinib |
74
|
285
|
8d6eA |
Crystal structure of human myt1 kinase domain bounded with rp-6306 |
73
|
284
|
8d6dA |
Crystal structure of human myt1 kinase domain bounded with compound 39 |
74
|
284
|
8d6fA |
Crystal structure of human myt1 kinase domain bounded with eph receptor inhibitor / compound 41 |
74
|
285
|
8d6cA |
Crystal structure of human myt1 kinase domain bounded with compound 28 |
107
|
394
|
7p6nA |
Rock2 in complex with compound 12 |
86
|
280
|
8a66A |
Crystal structure of mst2 in complex with xmu-mp-1 |
92
|
291
|
7up7A |
Crystal structure of c-terminal domain of msk1 in complex with covalently bound with literature rsk2 inhibitor indazole cyanoacrylamide compound 26 (soak) |
139
|
480
|
7wdcA |
Crystal structure of cyanobacterial circadian clock protein kaic |
74
|
274
|
7xsvA |
Crystal structures of pim1 in complex with macrocyclic compound h3 |
74
|
275
|
7p3vA |
B-raf v600e structure bound to a new inhibitor |
236
|
948
|
6xrnA |
Crystal structure of human pi3k-gamma in complex with compound 17 |
310
|
946
|
7jiuA |
Human pi3kdelta in complex with compound 2f |
49
|
134
|
7p4sA |
Bromodomain of human taf1 (2) with naphthyridinone compound |
18
|
97
|
7okwA |
1.62a x-ray crystal structure of the conserved c-terminal (cct) of human osr1 |
22
|
96
|
7o86A |
1.73a x-ray crystal structure of the conserved c-terminal (cct) of human spak |
83
|
273
|
7oowA |
Crystal structure of pim1 in complex with arc-1415 |
85
|
273
|
7oovA |
Crystal structure of pim1 in complex with arc-1411 |
30
|
125
|
7o3bG |
Crystal structure of the ttbk2-cep164 complex bound to a camelid nanobody |
513
|
1541
|
7ni6A |
Human atm kinase with bound atpys |
117
|
442
|
7nh5A |
Co-crystal structure of akt1 in complex with covalent-allosteric akt inhibitor 6 |
114
|
441
|
7nh4A |
Co-crystal structure of akt1 in complex with covalent-allosteric akt inhibitor 3 |
67
|
276
|
7naaA |
Crystal structure of mycobacterium tuberculosis h37rv pknf kinase domain |
290
|
1052
|
7mezA |
Structure of the phosphoinositide 3-kinase p110 gamma (pik3cg) p101 (pik3r5) complex |
75
|
295
|
7lvhA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand n-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
83
|
297
|
7lviA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand (2r)-2-amino-n-[3-methoxy-4- (1,3-oxazol-5-yl)phenyl]-4-methylpentanamide |
79
|
268
|
7kx6A |
Crystal structure of dclk1-kd in complex with xmd8-85 |
101
|
328
|
7l1xA |
Structure of human ck2 alpha kinase (catalytic subunit) with the inhibitor 108600. |
69
|
267
|
7kxwA |
Crystal structure of dclk1-kd in complex with dclk1-in-1 |
73
|
268
|
7kxwB |
Crystal structure of dclk1-kd in complex with dclk1-in-1 |
64
|
288
|
7kx8A |
Crystal structure of dclk1-cter in complex with fmf-03-055-1 |
99
|
252
|
7k6fA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 in complex with mes (2-(n-morpholino)ethanesulfonic acid) |
48
|
123
|
7k42A |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to dioxane |